Nanohale AG (ETR:FYB) | WebDisclosure

Basculer en Français

9560	Companies
188851	Keywords
120589	Articles
100789	Press releases

Home
Companies
Nanohale AG

BRIEF

published on 10/02/2025 at 06:35, 2 months 19 days ago

Formycon obtient une licence américaine pour le biosimilaire d'Aflibercept

Formycon AG Lancement Sur Le Marché Américain Biosimilaire D'Aflibercept Accord Regeneron Résolution Des Litiges En Matière De Brevets
BRIEF

published on 10/02/2025 at 06:35, 2 months 19 days ago

Formycon Secures U.S. License for Aflibercept Biosimilar

Formycon AG U.S. Market Launch Aflibercept Biosimilar Regeneron Agreement Patent Dispute Resolution
PRESS RELEASE

published on 10/02/2025 at 06:30, 2 months 19 days ago

Formycon secures U.S. License Date for proposed Aflibercept Biosimilar FYB203 following settlement and license agreement with Regeneron
Formycon secures U.S. License Date for proposed Aflibercept Biosimilar FYB203 following settlement and license agreement with Regeneron. Commercial launch expected in Q4/2026

Formycon Regeneron Valorum Biologics Aflibercept Biosimilar Patent Disputes
BRIEF

published on 09/17/2025 at 16:00, 3 months 4 days ago

Formycon AG: Updated Research and Performance Forecast

Revenue Forecast Biosimilars Formycon FYB202 FYB206
BRIEF

published on 09/17/2025 at 16:00, 3 months 4 days ago

Formycon AG : Recherche et prévisions de performance actualisées

Prévisions De Revenus Formycon FYB202 Biosimilaires FYB206
PRESS RELEASE

published on 09/17/2025 at 15:55, 3 months 4 days ago

Original-Research: Formycon AG (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research GmbH updates rating on Formycon AG (ISIN: DE000A1EWVY8) to Buy with a target price of €48. Analyst expects revenue to rebound in H2 and Q4 due to FYB202 and FYB206 developments

First Berlin Equity Research BUY Rating Formycon AG Update Target Price
BRIEF

published on 09/17/2025 at 06:35, 3 months 4 days ago

Horus Pharma Joins Formycon's Eylea® Biosimilar Commercialization

Commercialization Biosimilar Formycon Baiama Horus Pharma
BRIEF

published on 09/17/2025 at 06:35, 3 months 4 days ago

Horus Pharma rejoint la commercialisation du biosimilaire Eylea® de Formycon

Commercialisation Formycon Biosimilaire Baiama Horus Pharma
PRESS RELEASE

published on 09/17/2025 at 06:30, 3 months 4 days ago

Horus Pharma becomes additional commercialization partner for Formycon's Eylea® biosimilar FYB203 in selected European countries under the brand name Baiama®
Horus Pharma partners with Formycon for Eylea biosimilar commercialization in Europe under Baiama brand. Agreement includes upfront payments and royalties for Klinge. Aflibercept treats nAMD

Agreement Formycon Eylea Biosimilar Horus Pharma Baiama Brand
BRIEF

published on 08/13/2025 at 06:35, 4 months 8 days ago

Formycon Affirms Full-Year Outlook After Strategic Developments

Formycon AG Corporate Bond Biosimilar Market 2025 Financial Guidance FYB202 & FYB206

Accesswire

Published on 12/20/2025 at 00:30, 1 day 21 hours ago

Alphinat Announces a Profit of $120,155 for Fiscal Year Ended August 31, 2025
Published on 12/19/2025 at 22:00, 1 day 23 hours ago

GMV Minerals Inc. Closes Non-Brokered Equity Financing
Published on 12/19/2025 at 18:30, 2 days 3 hours ago

Eagle Plains Shareholders Approve all Matters at Annual General Meeting
Published on 12/19/2025 at 14:40, 2 days 7 hours ago

Northern Superior Announces Closing of the Arrangement
Published on 12/19/2025 at 13:30, 2 days 8 hours ago

Quartz Commences Trading On The OTCQX Best Market Under The Symbol QZMRF

View all ACCESSWIRE

EQS Group

Published on 12/21/2025 at 08:55, 12 hours 45 minutes ago

Vantage Markets recognised for real-time threat intelligence collaboration with Trend Micro
Published on 12/20/2025 at 16:45, 1 day 4 hours ago

Shanghai Electric Powers Up Iraq's Energy Future with Major 625MW Efficiency Upgrade
Published on 12/20/2025 at 10:05, 1 day 11 hours ago

FITUR 2026 highlights the strong synergies between Germany and Spain
Published on 12/19/2025 at 22:03, 1 day 23 hours ago

EAMD: Trading resumes on the Düsseldorf Stock Exchange, lawsuit filed by minority shareholders dismissed, capital increase for investments in drone projects in the defense tech sector
Published on 12/19/2025 at 21:40, 2 days ago

IMG Saxony-Anhalt: 2026 in Sight - Saxony-Anhalt Sets the Pace for Future Industries

Les Echos

Published on 12/19/2025 at 21:57, 1 day 23 hours ago

Mise à disposition du document d’enregistrement universel
Published on 12/19/2025 at 08:30, 2 days 13 hours ago

Share capital decrease by way of treasury shares cancellation
Published on 12/19/2025 at 08:30, 2 days 13 hours ago

Réduction du capital par voie d’annulation d’actions propres
Published on 12/19/2025 at 07:00, 2 days 14 hours ago

EURAZEO ANNONCE AVOIR MENÉ AVEC SUCCÈS UNE TRANSACTION ACCÉLÉRANT SA ROTATION D'ACTIFS
Published on 12/19/2025 at 07:00, 2 days 14 hours ago

EURAZEO ANNOUNCES A SUCCESSFUL TRANSACTION ACCELERATING ITS ASSET ROTATION

View all LES ECHOS COMFI WIRE